Kingsview Wealth Management LLC Sells 2,209 Shares of CVS Health Corporation $CVS

Kingsview Wealth Management LLC cut its holdings in CVS Health Corporation (NYSE:CVS) by 8.1% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 25,092 shares of the pharmacy operator’s stock after selling 2,209 shares during the period. Kingsview Wealth Management LLC’s holdings in CVS Health were worth $1,731,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. IFP Advisors Inc raised its stake in shares of CVS Health by 8.6% in the first quarter. IFP Advisors Inc now owns 23,256 shares of the pharmacy operator’s stock worth $1,576,000 after buying an additional 1,843 shares during the period. J.W. Cole Advisors Inc. purchased a new stake in CVS Health in the 1st quarter worth approximately $1,578,000. GW&K Investment Management LLC increased its holdings in CVS Health by 39.4% in the 1st quarter. GW&K Investment Management LLC now owns 637 shares of the pharmacy operator’s stock worth $43,000 after acquiring an additional 180 shares in the last quarter. Crestwood Advisors Group LLC raised its stake in CVS Health by 3.4% during the 1st quarter. Crestwood Advisors Group LLC now owns 20,033 shares of the pharmacy operator’s stock worth $1,357,000 after acquiring an additional 653 shares during the period. Finally, Universal Beteiligungs und Servicegesellschaft mbH lifted its holdings in CVS Health by 1.4% during the first quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 708,479 shares of the pharmacy operator’s stock valued at $47,999,000 after purchasing an additional 9,634 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the stock. Wall Street Zen downgraded shares of CVS Health from a “buy” rating to a “hold” rating in a research report on Saturday, November 1st. The Goldman Sachs Group assumed coverage on CVS Health in a research note on Tuesday, October 14th. They issued a “buy” rating and a $91.00 price target for the company. Wells Fargo & Company decreased their price target on CVS Health from $103.00 to $102.00 and set an “overweight” rating on the stock in a report on Thursday, November 13th. Baird R W raised CVS Health from a “hold” rating to a “strong-buy” rating in a research note on Thursday, August 14th. Finally, UBS Group increased their target price on CVS Health from $79.00 to $96.00 and gave the stock a “buy” rating in a research report on Friday, October 24th. Two investment analysts have rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $89.41.

CVS Health Trading Down 1.8%

Shares of CVS Health stock opened at $76.52 on Thursday. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $85.15. The company has a quick ratio of 0.62, a current ratio of 0.83 and a debt-to-equity ratio of 0.83. The business has a 50-day moving average price of $78.03 and a 200-day moving average price of $70.14. The firm has a market cap of $97.13 billion, a price-to-earnings ratio of 201.36, a PEG ratio of 0.87 and a beta of 0.60.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.24. The company had revenue of $102.87 billion for the quarter, compared to the consensus estimate of $98.85 billion. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The firm’s revenue for the quarter was up 7.8% on a year-over-year basis. During the same period in the previous year, the business earned $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Equities research analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, November 3rd. Investors of record on Thursday, October 23rd were issued a $0.665 dividend. The ex-dividend date of this dividend was Thursday, October 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.5%. CVS Health’s dividend payout ratio (DPR) is 700.00%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.